Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Cash from Investing Activities (2023 - 2025)

Historic Cash from Investing Activities for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$96.6 million.

  • Nuvation Bio's Cash from Investing Activities fell 43184.85% to -$96.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.2 million, marking a year-over-year decrease of 3831.63%. This contributed to the annual value of $122.7 million for FY2024, which is 127544.0% up from last year.
  • Nuvation Bio's Cash from Investing Activities amounted to -$96.6 million in Q3 2025, which was down 43184.85% from $54.9 million recorded in Q2 2025.
  • Nuvation Bio's Cash from Investing Activities' 5-year high stood at $54.9 million during Q2 2025, with a 5-year trough of -$96.6 million in Q3 2025.
  • Its 3-year average for Cash from Investing Activities is $13.1 million, with a median of $33.2 million in 2023.
  • Data for Nuvation Bio's Cash from Investing Activities shows a peak YoY increase of 61840.36% (in 2025) and a maximum YoY decrease of 43184.85% (in 2025) over the last 5 years.
  • Nuvation Bio's Cash from Investing Activities (Quarter) stood at $33.2 million in 2023, then soared by 56.11% to $51.8 million in 2024, then crashed by 286.63% to -$96.6 million in 2025.
  • Its last three reported values are -$96.6 million in Q3 2025, $54.9 million for Q2 2025, and $54.2 million during Q1 2025.